Get started
Author

Lauren S. Fink

Observed names: Lauren Fink, Lauren Sara Koltowski Fink, Lauren S. Fink
OpenAlex ID: A5062583319
Resistance to BET Bromodomain Inhibitors Is Mediated by Kinome Reprogramming in Ovarian Cancer
2016 · Alison M. Kurimchak, Claude Shelton, et al. · Cell Reports · 198
PDF
Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2017 · Alexander Beatty, Lauren S. Fink, et al. · Molecular Cancer Therapeutics · 65
PDF
Identifying three-dimensional structures of autophosphorylation complexes in crystals of protein kinases
2015 · Qifang Xu, Kimberly L. Malecka, et al. · Science Signaling · 42
53BP1 contributes to a robust genomic stability in human fibroblasts
2011 · Lauren S. Fink, Michaela Roell, et al. · Aging · 30
PDF
Ku80 facilitates chromatin binding of the telomere binding protein, TRF2
2010 · Lauren S. Fink, Chad A. Lerner, et al. · Cell Cycle · 19
PDF
Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2014 · Lauren S. Fink, Alexander Beatty, et al. · Molecular Cancer Therapeutics · 14
A High-Content Screening Assay for Small-Molecule Modulators of Oncogene-Induced Senescence
2013 · Benjamin G. Bitler, Lauren S. Fink, et al. · SLAS DISCOVERY · 12
PDF
Relationship of spindle assembly checkpoint fidelity to species body mass, lifespan, and developmental rate
2011 · Antonello Lorenzini, Lauren S. Fink, et al. · Aging · 9
PDF
Network modeling of kinase inhibitor polypharmacology reveals pathways targeted in chemical screens
2017 · Oana Ursu, Sara J. C. Gosline, et al. · PLoS ONE · 3
PDF
Data from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2023 · Lauren S. Fink, Alexander Beatty, et al.
Data from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Data from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Table S2 from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Table S1 from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Table S3 from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Supplementary Figures from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
PDF
Table S3 from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Table S2 from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Supplementary Figures from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Table S1 from Metabolite Profiling Reveals the Glutathione Biosynthetic Pathway as a Therapeutic Target in Triple-Negative Breast Cancer
2023 · Alexander Beatty, Lauren S. Fink, et al.
Supplementary Table 5 from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2023 · Lauren S. Fink, Alexander Beatty, et al.
Supplementary Table 2 from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2023 · Lauren S. Fink, Alexander Beatty, et al.
Supplementary Figure Legends from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2023 · Lauren S. Fink, Alexander Beatty, et al.
Supplementary Table 4 from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2023 · Lauren S. Fink, Alexander Beatty, et al.
Supplementary Figure 1 from Pharmacological Profiling of Kinase Dependency in Cell Lines across Triple-Negative Breast Cancer Subtypes
2023 · Lauren S. Fink, Alexander Beatty, et al.
PDF
Works count: 46
Citation count: 393
H-index: 8
I10-index: 7
Year
Topic
Type